NEW HORIZONS DIAGNOSTICS INC has a total of 43 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are BROOKWOOD PHARMACEUTICALS INC, INST OF HIGH ENERGY PHYSICS CH and LAFOR LAB LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | Israel | 3 | |
#7 | Mexico | 3 | |
#8 | New Zealand | 3 | |
#9 | China | 2 | |
#10 | Republic of Korea | 2 | |
#11 | South Africa | 2 | |
#12 | Hong Kong | 1 | |
#13 | India | 1 | |
#14 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Medical technology | |
#6 | Measurement | |
#7 | Foods and drinks | |
#8 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Unspecified technologies | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies | |
#6 | Object sterilising | |
#7 | Analysing materials | |
#8 | Enzymes | |
#9 | Soaps |
# | Name | Total Patents |
---|---|---|
#1 | Loomis Lawrence | 35 |
#2 | Fischetti Vincent | 28 |
#3 | Fischetti V | 2 |
#4 | Lawrence Loomis | 2 |
#5 | Loomis L | 2 |
#6 | Vincent Fischetti | 1 |
#7 | Nelson Daniel | 1 |
#8 | Loomis Lawerence | 1 |
#9 | Loeffler Jutta | 1 |
#10 | Fischettie Vincent | 1 |
Publication | Filing date | Title |
---|---|---|
AU2005232261A1 | Topical treatment of streptococcal infections | |
AU2005227384A1 | The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses | |
WO2005077046A2 | A composition and method of treating mastitis | |
AU2005200385A1 | A means for the prophylactic and therapeutic treatment of streptococcal infections | |
IL148641D0 | Topical treatment of streptococcal infections | |
WO9964864A1 | Optimizing sensitivity in colloidal colorimetric flow through and lateral flow tests | |
AU4562599A | Colloidal colorimetric flow through and lateral flow assays utilizing soluble submicron particles | |
WO0050069A1 | A means for the prophylactic and therapeutic treatment of streptococcal infections | |
CN1352567A | A means for the prophylactic and therapeutic treamtent of streptococcal infections | |
NZ514260A | A composition comprising Group C streptococcal phage associated lysin enzyme, and the use of this composition for preventing or treating streptoccocal infections | |
KR20020000217A | A means for the prophylactic and therapeutic treatment of streptococcal infections |